Angela Buonadonna

9PUBLICATIONS
37CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Intensive care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 11, 2024
Null Mismatch Repair Proteins Expression Reveals the Temporal Molecular Events in Lynch Syndrome-Related Cancers.

Gianmaria Miolo, Wally Marus, Angela Buonadonna

|Nov 13, 2023
Therapeutic drug monitoring and pharmacogenetics to tune imatinib exposure in gastrointestinal stromal tumor patients: hurdles and perspectives for clinical implementation.

Sara Gagno, Chiara Dalle Fratte, Bianca Posocco

|Oct 28, 2023
Prospective, Multicenter Phase II Trial of Non-Pegylated Liposomal Doxorubicin Combined with Ifosfamide in First-Line Treatment of Advanced/Metastatic Soft Tissue Sarcomas.

Angela Buonadonna, Simona Scalone, Davide Lombardi

|Oct 27, 2023
Metabolic Clues to Bile Acid Patterns and Prolonged Survival in Patients with Metastatic Soft-Tissue Sarcoma Treated with Trabectedin.

Gianmaria Miolo, Angela Buonadonna, Simona Scalone

|Feb 25, 2023
Impact of ABCG2 and ABCB1 Polymorphisms on Imatinib Plasmatic Exposure: An Original Work and Meta-Analysis.

Chiara Dalle Fratte, Jerry Polesel, Sara Gagno

|Jan 08, 2023
The SAFFO Study: Sex-Related Prognostic Role and Cut-Off Definition of Monocyte-to-Lymphocyte Ratio (MLR) in Metastatic Colorectal Cancer.

Camilla Lisanti, Debora Basile, Silvio Ken Garattini

Pageof 2

Frequent Collaborators

5 joint publications

Fabio Puglisi

3 joint publications

Gianmaria Miolo

3 joint publications

Jerry Polesel

3 joint publications

Giuseppe Toffoli